News
Moderna gets FDA okay for RSV vaccine mResvia
Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax C
Sunday 24 November 2024
